OnDemand Retina Service Update Featuring the 13th Annual J. Arch McNamara, MD Memorial Lecture

Thursday, December 14, 2023, 10:50 AM - Saturday, December 14, 2024, 11:00 PM


AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours)

With the emergence of new technologies, treatments, and clinical trial results, ophthalmologists need to understand how to incorporate these advances into clinical care. We will discuss latest advances in the management of inherited and acquired ophthalmic diseases and evidence for emerging therapies and screening modalities. Both didactic and case-based educational formats will be utilized to illustrate current trends in the management of complex and routine ophthalmic patients, taking into account diagnostics as well as nonsurgical and surgical treatment.

Thank you to our Exhibitors!
Alcon
Allergan
Apellis
Bausch + Lomb
Coherus Biosciences
Genentech
Regeneron

1. Evaluate Avacincaptad vs. Pegtacoplan treatments for patients with GA
2. Collaborate with peers in preparation for surgical interventions involving areas of the eye outside of Retina & Vitreous
3. Speak with patients about complications and side effects of various retinal disease treatments including GA
4. Develop treatment plans for posterior segment complications from anterior segment surgery

AMA PRA Statement
Wills Eye Hospital designates this Enduring Material for a maximum of 4.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the full list of faculty and disclosures, click here to download the course brochure.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.